Siriuspoint

SPNT · NYSE

$25.52+$0.31 (+1.23%)TodayMarket closed ·
Prev close $25.21

About SPNT

SiriusPoint Ltd. engages in the provision of insurance and reinsurance services. The company employs 1,099 full-time employees The company went IPO on 2013-08-15. The firm has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty.

Employees
1,068
Headquarters
Pembroke
Listed
Aug 15, 2013
Sector
Financials
Industry
Insurance

SPNT key statistics

Market cap
2.96B
Price-earnings ratio
6.21
Dividend yield
0.45%
Average volume
969.13K
Volume
580.71K
Open price
$25.36
High today
$25.64
Low today
$25.21
52 Week high
$26.50
52 Week low
$17.45

Siriuspoint (SPNT) at a glance

Siriuspoint (SPNT) last traded at $25.52, with a market cap of 2.96B, a price-to-earnings ratio of 6.21 and a dividend yield of 0.45%.

Today the stock has traded between $25.21 and $25.64. The current price is 1.2% above the day's low and 0.4% below its high.

Volume so far is 580.71K shares, below the average of 969.13K shares a day.

Over the past year Siriuspoint has ranged from $17.45 to $26.50, and now sits 89% of the way up that range.

Siriuspoint met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.58 per share against an estimate of $0.6506.

The average analyst price target is $25.42, 0.4% below the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 7 analystsAvg $25.42
Low
$11.73
Now
$25.52
High
$32.55

SPNT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 104.5% on average.

  1. Q3 FY24: reported $0.03 per share against an estimate of $0.051
  2. Q4 FY24: reported -$0.13 per share against an estimate of $0.408
  3. Q1 FY25: reported $0.49 per share against an estimate of $0.2346
  4. Q2 FY25: reported $0.50 per share against an estimate of $0.5799
  5. Q3 FY25: reported $0.73 per share against an estimate of $0.5202
  6. Q4 FY25: reported $1.97 per share against an estimate of $0.561
  7. Q1 FY26: reported $0.82 per share against an estimate of $0.6963
  8. Q2 FY26: reported $0.58 per share against an estimate of $0.6506

SPNT news

  • Press releaseBusiness Wire

    AM Best Upgrades Credit Ratings of SiriusPoint Ltd. and Its Subsidiaries

  • Preview: SiriusPoint's Earnings

  • Press releaseBusiness Wire

    Ambac Financial Group to Acquire Leading Supplemental Health Program Manager ArmadaCare

  • Press releaseBusiness Wire

    AM Best Revises Outlooks to Positive for SiriusPoint Ltd. and Its Subsidiaries

  • SiriusPoint Announces Strategic Partnership With Holmes Murphy To Launch New Captive-Focused Umbrella Excess Insurance Product

  • Vandana Singh

    Why Is Insurer SiriusPoint Stock Trading Higher On Tuesday?

  • 'SiriusPoint Announces New Partnership With Travel Insurtech Gigasure' - SiriusPoint

Similar companies

Companies in the same industry as Siriuspoint

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.